 | • レポートコード：QYR9ST00121 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のうつ病用治療市場について調査・分析し、以下の構成でお届け致します。うつ病用治療の種類別には、選択的セロトニン再取り込み阻害剤（SSRI）、選択的ノルエピネフリン再取り込み阻害剤（SNRI）、その他に、用途別には、病院薬局、小売薬局、オンライン薬局に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別うつ病用治療売上データ ・地域別うつ病用治療市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別うつ病用治療市場規模：選択的セロトニン再取り込み阻害剤（SSRI）、選択的ノルエピネフリン再取り込み阻害剤（SNRI）、その他 ・用途別うつ病用治療市場規模：病院薬局、小売薬局、オンライン薬局 ・主要メーカーの企業情報：Pfizer, Inc、Eli Lilly and Company、AstraZeneca, Plc、Allergan Plc、GlaxoSmithKline Plc、Intellipharmaceutics International, Inc、Takeda Pharmaceutical Company Limited、H.Lundbeck A/S、Otsuka Holdings Co.,Ltd、Apotex, Inc、Shionogi & Co. Ltd、Zhejiang Hua Hai Pharmaceutical Co., Ltd、Chengdu Kanghong Pharmaceutical Group ・うつ病用治療の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior.The global Depression Therapeutics market is valued at 12400 million US$ in 2018 and will reach 14700 million US$ by the end of 2025, growing at a CAGR of 2.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Depression Therapeutics market based on company, product type, end user and key regions.
This report studies the global market size of Depression Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Depression Therapeutics in these regions.
This research report categorizes the global Depression Therapeutics market by top players/brands, region, type and end user. This report also studies the global Depression Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer, Inc
Eli Lilly and Company
AstraZeneca, Plc
Allergan Plc
GlaxoSmithKline Plc
Intellipharmaceutics International, Inc
Takeda Pharmaceutical Company Limited
H.Lundbeck A/S
Otsuka Holdings Co.,Ltd
Apotex, Inc
Shionogi & Co. Ltd
Zhejiang Hua Hai Pharmaceutical Co., Ltd
Chengdu Kanghong Pharmaceutical Group
Market size by Product
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Others
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Depression Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Depression Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Depression Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Depression Therapeutics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Depression Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Depression Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Depression Therapeutics Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Depression Therapeutics Market Size Growth Rate by Product
1.4.2 Selective Serotonin Reuptake Inhibitors (SSRIs)
1.4.3 Selective Norepinephrine Reuptake Inhibitors (SNRIs)
1.4.4 Others
1.5 Market by End User
1.5.1 Global Depression Therapeutics Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Depression Therapeutics Market Size
2.1.1 Global Depression Therapeutics Revenue 2014-2025
2.1.2 Global Depression Therapeutics Sales 2014-2025
2.2 Depression Therapeutics Growth Rate by Regions
2.2.1 Global Depression Therapeutics Sales by Regions
2.2.2 Global Depression Therapeutics Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Depression Therapeutics Sales by Manufacturers
3.1.1 Depression Therapeutics Sales by Manufacturers
3.1.2 Depression Therapeutics Sales Market Share by Manufacturers
3.1.3 Global Depression Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Depression Therapeutics Revenue by Manufacturers
3.2.1 Depression Therapeutics Revenue by Manufacturers (2014-2019)
3.2.2 Depression Therapeutics Revenue Share by Manufacturers (2014-2019)
3.3 Depression Therapeutics Price by Manufacturers
3.4 Depression Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Depression Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Depression Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Depression Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Depression Therapeutics Sales by Product
4.2 Global Depression Therapeutics Revenue by Product
4.3 Depression Therapeutics Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Depression Therapeutics Breakdown Data by End User
6 North America
6.1 North America Depression Therapeutics by Countries
6.1.1 North America Depression Therapeutics Sales by Countries
6.1.2 North America Depression Therapeutics Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Depression Therapeutics by Product
6.3 North America Depression Therapeutics by End User
7 Europe
7.1 Europe Depression Therapeutics by Countries
7.1.1 Europe Depression Therapeutics Sales by Countries
7.1.2 Europe Depression Therapeutics Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Depression Therapeutics by Product
7.3 Europe Depression Therapeutics by End User
8 Asia Pacific
8.1 Asia Pacific Depression Therapeutics by Countries
8.1.1 Asia Pacific Depression Therapeutics Sales by Countries
8.1.2 Asia Pacific Depression Therapeutics Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Depression Therapeutics by Product
8.3 Asia Pacific Depression Therapeutics by End User
9 Central & South America
9.1 Central & South America Depression Therapeutics by Countries
9.1.1 Central & South America Depression Therapeutics Sales by Countries
9.1.2 Central & South America Depression Therapeutics Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Depression Therapeutics by Product
9.3 Central & South America Depression Therapeutics by End User
10 Middle East and Africa
10.1 Middle East and Africa Depression Therapeutics by Countries
10.1.1 Middle East and Africa Depression Therapeutics Sales by Countries
10.1.2 Middle East and Africa Depression Therapeutics Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Depression Therapeutics by Product
10.3 Middle East and Africa Depression Therapeutics by End User
11 Company Profiles
11.1 Pfizer, Inc
11.1.1 Pfizer, Inc Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer, Inc Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer, Inc Depression Therapeutics Products Offered
11.1.5 Pfizer, Inc Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly and Company Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Eli Lilly and Company Depression Therapeutics Products Offered
11.2.5 Eli Lilly and Company Recent Development
11.3 AstraZeneca, Plc
11.3.1 AstraZeneca, Plc Company Details
11.3.2 Company Business Overview
11.3.3 AstraZeneca, Plc Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AstraZeneca, Plc Depression Therapeutics Products Offered
11.3.5 AstraZeneca, Plc Recent Development
11.4 Allergan Plc
11.4.1 Allergan Plc Company Details
11.4.2 Company Business Overview
11.4.3 Allergan Plc Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Allergan Plc Depression Therapeutics Products Offered
11.4.5 Allergan Plc Recent Development
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Plc Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Plc Depression Therapeutics Products Offered
11.5.5 GlaxoSmithKline Plc Recent Development
11.6 Intellipharmaceutics International, Inc
11.6.1 Intellipharmaceutics International, Inc Company Details
11.6.2 Company Business Overview
11.6.3 Intellipharmaceutics International, Inc Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Intellipharmaceutics International, Inc Depression Therapeutics Products Offered
11.6.5 Intellipharmaceutics International, Inc Recent Development
11.7 Takeda Pharmaceutical Company Limited
11.7.1 Takeda Pharmaceutical Company Limited Company Details
11.7.2 Company Business Overview
11.7.3 Takeda Pharmaceutical Company Limited Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Takeda Pharmaceutical Company Limited Depression Therapeutics Products Offered
11.7.5 Takeda Pharmaceutical Company Limited Recent Development
11.8 H.Lundbeck A/S
11.8.1 H.Lundbeck A/S Company Details
11.8.2 Company Business Overview
11.8.3 H.Lundbeck A/S Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.8.4 H.Lundbeck A/S Depression Therapeutics Products Offered
11.8.5 H.Lundbeck A/S Recent Development
11.9 Otsuka Holdings Co.,Ltd
11.9.1 Otsuka Holdings Co.,Ltd Company Details
11.9.2 Company Business Overview
11.9.3 Otsuka Holdings Co.,Ltd Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Otsuka Holdings Co.,Ltd Depression Therapeutics Products Offered
11.9.5 Otsuka Holdings Co.,Ltd Recent Development
11.10 Apotex, Inc
11.10.1 Apotex, Inc Company Details
11.10.2 Company Business Overview
11.10.3 Apotex, Inc Depression Therapeutics Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Apotex, Inc Depression Therapeutics Products Offered
11.10.5 Apotex, Inc Recent Development
11.11 Shionogi & Co. Ltd
11.12 Zhejiang Hua Hai Pharmaceutical Co., Ltd
11.13 Chengdu Kanghong Pharmaceutical Group
12 Future Forecast
12.1 Depression Therapeutics Market Forecast by Regions
12.1.1 Global Depression Therapeutics Sales Forecast by Regions 2019-2025
12.1.2 Global Depression Therapeutics Revenue Forecast by Regions 2019-2025
12.2 Depression Therapeutics Market Forecast by Product
12.2.1 Global Depression Therapeutics Sales Forecast by Product 2019-2025
12.2.2 Global Depression Therapeutics Revenue Forecast by Product 2019-2025
12.3 Depression Therapeutics Market Forecast by End User
12.4 North America Depression Therapeutics Forecast
12.5 Europe Depression Therapeutics Forecast
12.6 Asia Pacific Depression Therapeutics Forecast
12.7 Central & South America Depression Therapeutics Forecast
12.8 Middle East and Africa Depression Therapeutics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Depression Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Depression Therapeutics Product Picture
Table Depression Therapeutics Market Segments
Table Key Manufacturers Depression Therapeutics Covered
Table Global Depression Therapeutics Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Depression Therapeutics Sales Market Share by Product 2014-2025
Figure Selective Serotonin Reuptake Inhibitors (SSRIs) Product Picture
Table Major Manufacturers of Selective Serotonin Reuptake Inhibitors (SSRIs)
Figure Selective Norepinephrine Reuptake Inhibitors (SNRIs) Product Picture
Table Major Manufacturers of Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Depression Therapeutics Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Online Pharmacies
Figure Depression Therapeutics Report Years Considered
Figure Global Depression Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Depression Therapeutics Sales 2014-2025 (K Units)
Table Global Depression Therapeutics Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Depression Therapeutics Sales by Regions 2014-2019 (K Units)
Table Global Depression Therapeutics Sales Market Share by Regions 2014-2019
Figure Global Depression Therapeutics Sales Market Share by Regions 2014-2019
Figure 2018 Global Depression Therapeutics Sales Market Share by Regions
Table Global Depression Therapeutics Revenue by Regions 2014-2019 (Million US$)
Table Global Depression Therapeutics Revenue Market Share by Regions 2014-2019
Figure Global Depression Therapeutics Revenue Market Share by Regions 2014-2019
Figure 2018 Global Depression Therapeutics Revenue Market Share by Regions
Table Global Depression Therapeutics Sales by Manufacturers (2014-2019) (K Units)
Table Global Depression Therapeutics Sales Share by Manufacturers (2014-2019)
Figure Global Depression Therapeutics Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Depression Therapeutics Revenue by Manufacturers (2014-2019) (Million USD)
Table Depression Therapeutics Revenue Share by Manufacturers (2014-2019)
Figure Depression Therapeutics Value Share by Manufacturers in 2018
Table Key Manufacturers Depression Therapeutics Price (2014-2019) (USD/Unit)
Table Depression Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Depression Therapeutics Product Type
Table Date of International Manufacturers Enter into Depression Therapeutics Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Depression Therapeutics Sales by Product (2014-2019) (K Units)
Table Global Depression Therapeutics Sales Share by Product (2014-2019)
Figure Global Depression Therapeutics Sales Market Share by Product (2014-2019)
Figure Global Depression Therapeutics Sales Market Share by Product in 2018
Table Global Depression Therapeutics Revenue by Product (2014-2019) (Million US$)
Table Global Depression Therapeutics Revenue Share by Product (2014-2019)
Figure Global Depression Therapeutics Revenue Market Share by Product (2014-2019)
Figure Global Depression Therapeutics Revenue Market Share by Product in 2018
Table Depression Therapeutics Price by Product 2014-2019 (USD/Unit)
Table Global Depression Therapeutics Sales by End User (2014-2019) (K Units)
Table Global Depression Therapeutics Sales Share by End User (2014-2019)
Figure Global Sales Depression Therapeutics Market Share by End User (2014-2019)
Figure Global Sales Depression Therapeutics Market Share by End User in 2018
Figure North America Depression Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure North America Depression Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table North America Depression Therapeutics Sales by Countries (2014-2019) (K Units)
Table North America Depression Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 North America Depression Therapeutics Sales Market Share by Countries
Table North America Depression Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table North America Depression Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Depression Therapeutics Revenue Market Share by Countries
Figure United States Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure United States Depression Therapeutics Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Canada Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table North America Depression Therapeutics Sales by Product (2014-2019) (K Units)
Table North America Depression Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 North America Depression Therapeutics Market Share by Product
Table North America Depression Therapeutics Sales by End User (2014-2019) (K Units)
Table North America Depression Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 North America Depression Therapeutics Market Share by End User
Figure Europe Depression Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Europe Depression Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Depression Therapeutics Sales by Countries (2014-2019) (K Units)
Table Europe Depression Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Depression Therapeutics Sales Market Share by Countries
Table Europe Depression Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Europe Depression Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Depression Therapeutics Revenue Market Share by Countries
Figure Germany Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Germany Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure France Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure France Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure UK Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Italy Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Russia Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Depression Therapeutics Sales by Product (2014-2019) (K Units)
Table Europe Depression Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Europe Depression Therapeutics Market Share by Product
Table Europe Depression Therapeutics Sales by End User (2014-2019) (K Units)
Table Europe Depression Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Europe Depression Therapeutics Market Share by End User
Figure Asia Pacific Depression Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Depression Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Depression Therapeutics Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Depression Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Depression Therapeutics Sales Market Share by Countries
Table Asia Pacific Depression Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Depression Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Depression Therapeutics Revenue Market Share by Countries
Figure China Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure China Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Japan Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Korea Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure India Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure India Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Australia Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Depression Therapeutics Sales by Product (2014-2019) (K Units)
Table Asia Pacific Depression Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Depression Therapeutics Market Share by Product
Table Asia Pacific Depression Therapeutics Sales by End User (2014-2019) (K Units)
Table Asia Pacific Depression Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Depression Therapeutics Market Share by End User
Figure Central & South America Depression Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Depression Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Depression Therapeutics Sales by Countries (2014-2019) (K Units)
Table Central & South America Depression Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Depression Therapeutics Sales Market Share by Countries
Table Central & South America Depression Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Depression Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Depression Therapeutics Revenue Market Share by Countries
Figure Brazil Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Depression Therapeutics Sales by Product (2014-2019) (K Units)
Table Central & South America Depression Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Depression Therapeutics Market Share by Product
Table Central & South America Depression Therapeutics Sales by End User (2014-2019) (K Units)
Table Central & South America Depression Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Depression Therapeutics Market Share by End User
Figure Middle East and Africa Depression Therapeutics Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Depression Therapeutics Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Depression Therapeutics Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Depression Therapeutics Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Depression Therapeutics Sales Market Share by Countries
Table Middle East and Africa Depression Therapeutics Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Depression Therapeutics Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Depression Therapeutics Revenue Market Share by Countries
Figure GCC Countries Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Depression Therapeutics Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Depression Therapeutics Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Depression Therapeutics Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Depression Therapeutics Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Depression Therapeutics Market Share by Product
Table Middle East and Africa Depression Therapeutics Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Depression Therapeutics Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Depression Therapeutics Market Share by End User
Table Pfizer, Inc Company Details
Table Pfizer, Inc Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer, Inc Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development
Table AstraZeneca, Plc Company Details
Table AstraZeneca, Plc Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca, Plc Recent Development
Table Allergan Plc Company Details
Table Allergan Plc Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Allergan Plc Recent Development
Table GlaxoSmithKline Plc Company Details
Table GlaxoSmithKline Plc Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc Recent Development
Table Intellipharmaceutics International, Inc Company Details
Table Intellipharmaceutics International, Inc Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Intellipharmaceutics International, Inc Recent Development
Table Takeda Pharmaceutical Company Limited Company Details
Table Takeda Pharmaceutical Company Limited Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Company Limited Recent Development
Table H.Lundbeck A/S Company Details
Table H.Lundbeck A/S Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table H.Lundbeck A/S Recent Development
Table Otsuka Holdings Co.,Ltd Company Details
Table Otsuka Holdings Co.,Ltd Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Otsuka Holdings Co.,Ltd Recent Development
Table Apotex, Inc Company Details
Table Apotex, Inc Depression Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Apotex, Inc Recent Development
Table Shionogi & Co. Ltd Company Details
Table Zhejiang Hua Hai Pharmaceutical Co., Ltd Company Details
Table Chengdu Kanghong Pharmaceutical Group Company Details
Table Global Depression Therapeutics Sales Forecast by Regions 2019-2025 (K Units)
Table Global Depression Therapeutics Sales Market Share Forecast by Regions 2019-2025
Table Global Depression Therapeutics Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Depression Therapeutics Revenue Market Share Forecast by Regions 2019-2025
Table Global Depression Therapeutics Sales Forecast by Product 2019-2025 (K Units)
Table Global Depression Therapeutics Sales Market Share Forecast by Product 2019-2025
Table Global Depression Therapeutics Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Depression Therapeutics Revenue Market Share Forecast by Product 2019-2025
Table Global Depression Therapeutics Sales Forecast by End User 2019-2025 (K Units)
Table Global Depression Therapeutics Sales Market Share Forecast by End User 2019-2025
Figure North America Depression Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Depression Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Depression Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Depression Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Depression Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Depression Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Depression Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Depression Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Depression Therapeutics Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Depression Therapeutics Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Depression Therapeutics Value Chain
Table Depression Therapeutics Customers List
Table Depression Therapeutics Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
双極性障害治療法の世界市場：市場規模・現状・予測 Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. In 2018, the global Bipolar Disorder Therapeu…- 抗うつ薬の世界市場：インサイト・予測 Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. Antidepressants help maintain balance of various hormones and chemicals in the brain, which helps i…
- 抗うつ薬の世界市場：インサイト・予測 Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperact…
- 胃腸治療及び診断の世界市場：インサイト・予測 Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as ir…
- ナルコレプシー療法の世界市場：市場規模・現状・予測 Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.In 2018, the global Narcolepsy Therapeutics market size was xx mil…